The role of Alzheimer's disease–related plasma biomarkers in the depression–cognition association is investigated and Alzheimer's disease–related plasma biomarkers in the depression–cognition association are investigated.
Abstract
Late‐life depression is associated with cognitive impairment, but the underlying neural basis remains to be elucidated. We investigated the role of Alzheimer's disease (AD)–related plasma biomarkers in the depression–cognition association.
The Brain Care Score (BCS) was designed to engage patients in behavior change targeting modifiable risk factors for dementia, stroke, and depression. We investigated its associations with structural brain changes and cognitive function to evaluate its utility for early prevention.
Jenna Schellin, S. Sehner, Marie Neumann et al.· European Journal of Neurolog...· 0 citations
The findings underscore the heterogeneous nature of cognitive aging in OABD, revealing a spectrum of cognitive longitudinal trajectories and indicate that the MMSE is a valid screener in order to broadly predict cognitive functioning and its course in OABD.
Melis Orhan, E. Giltay, Azita Ghasemi et al.· Bipolar Disorders· 0 citations
Primary brain tumor (PBT) patients commonly experience cognitive dysfunction. This study aims to describe the prevalence and factors associated with perceived cognitive function (PCF) in PBT patients enrolled in a natural history study (NCT02851706: Principal Investigator T. S. Armstrong).
Morgan L. Johnson, Kimberly Reinhart, V. A. Guedes et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.